Drug Profile


Alternative Names: TZC 5665

Latest Information Update: 07 Jun 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Teikoku Hormone
  • Class Antihypertensives; Peripheral vasodilators; Pyridazines; Small molecules
  • Mechanism of Action Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure; Hypertension

Most Recent Events

  • 01 May 2005 Discontinued - Phase-II for Heart failure in Japan (unspecified route)
  • 09 Oct 1998 TZC 5665 is now called oberadilol (Rec INN)
  • 02 Aug 1995 Discontinued-Preclinical for Hypertension in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top